INTRODUCTION
NAFLD is now considered as a hepatic feature of metabolic syndrome. It is a rapidly growing disease in both developed and developing countries and is probably the most common cause of abnormal liver function tests worldwide. It is estimated to affect nearly 30% of general population in western countries (2) . Over the past couple of decades, it has become increasingly clear that NAFLD are now the number 1 cause of liver disease in the western countries. The prevalence of NAFLD has doubled during last 20 years, whereas the prevalence of other chronic liver diseases has remained stable or decreased (3).
The prevalence in Asian countries seems to be lower but is increasing secondary to an increase in burden of diabetes mellitus (DM), metabolic syndrome (MetS) and changing in lifestyle.
Although obesity is the commonest and primary metabolic cause, non alcoholic fatty liver disease may arise secondary to several other endocrine disorders, including thyroid dysfunction, growth hormone deficiency, adrenal insufficiency and polycystic ovary syndrome. The prevalence of hypothyroidism in patients with nonalcoholic fatty liver disease is twice that in patients with other chronic liver disease (15% v 7.2%) (4).
Several studies have investigated the association between thyroid hormone status and fatty liver disease. The results of those studies indicate that hypothyroidism might be related to hepatic steatosis because there are some common clinical and biochemical features of central obesity, insulin resistance, hypertension and hypertriglyceridemia observed in both NAFLD and hypothyroidism. But few studies revealed no significant association. The results of those previous studies on the role of fatty liver disease in thyroid abnormalities are inconsistent and there is no conclusive evidence about this.
In a developing country like Bangladesh, fatty liver disease is rapidly increasing and thyroid disorders are also common. There is no evidence based information available regarding the relation of thyroid hormone status with the severity of fatty liver disease in Bangladesh. So this study was designed to evaluate the thyroid function status in sonographically suggested fatty liver and to establish the necessity for investigation of thyroid function test in fatty liver subjects.
MATERIALS AND METHODS
This cross sectional study was carried out at the Institute of Nuclear Medicine and Allied Sciences (INMAS) of Dhaka Medical College Hospital Campus, Dhaka during the period of January 2014 to December 2014. Total 155 subjects were included by non-random purposive sampling. Sonographically detected fatty liver subjects aged 18 years or more were included. But patients with known thyroid disease, current or past history of thyroid hormone or antithyroid drug intake, hepatitis including liver cirrhosis, history of alcohol intake, any hepatotoxic drug intake, associated with any chronic debilitating illness and pregnant women were excluded from the study. All relevant data collected during the investigations were recorded on a pre-designed data collection sheet for each patient.
Abdominal ultrasound scanning was performed in all participants by a skilled sonologist, who was blind to all clinical and laboratory data of patients, using Accuvix V20 scanner, Samsung Medison (South Korea) with a 3.5-MHz curvilinear transducer. US examinations were performed after 6 hours fasting. Each subject was examined in the supine and left lateral positions during quiet inspiration. The presence of grading of fatty infiltration of the liver were recorded: Grade 1: Slight, diffuse increase in fine echoes in liver parenchyma with normal visualization of diaphragm and intrahepatic vessel borders, Grade 2: Moderate, diffuse increase in fine echoes with slightly impaired visualization of intrahepatic vessels and diaphragm, Grade 3: Marked, diffuse increase in fine echoes with poor or non visualization of the intrahepatic vessel borders, diaphragm and posterior right lobe of liver. Statistical analysis was performed using SPSS package 16.0 (SPSS Inc, Chicago, Illinois, USA). Categorical data was expressed in percentage or number. Parametric data was expressed in mean ± SD. Parametric data was evaluated by ANOVA test. Categorical data was evaluated by Chi square test. Significance was defined by p value ≤ 0.05. Spearman's rank correlation analysis was used to assess the correlation between variables.
Ethical consideration: This study was approved by the Medical Research Ethics Committee (MREC) of the National Institute of Nuclear Medicine and Allied Sciences, BSMMU campus, Shahbag, Dhaka.
RESULTS
Out of 155 fatty liver subjects 82 (52.9%) were in grade 1, 50 (32.3%) were grade 2 and 23 (14.8%) were grade 3 ( Table 1 ). Male to female ratio was almost 2:3 in the whole study subjects ( Table 2 ). The mean age was found 39±10.9 years in Grade 1, 39.5±10.4 years in Grade 2 and 41.4±7.1 years in Grade 3 ( Table 3 ). The mean BMI was found 26.9±3.6 kg/m2 in Grade 1, 29.2±4.5 kg/m2 in Grade 2 and 30.0±4.1 kg/m2 in Grade 3 (Table 4 ). Table 5 shows that mean FT3 and FT4 were significantly decreased with increased grades of fatty liver and mean TSH was increased with increased grade of fatty liver. Table 6 shows 6 patients (7.3%) had subclinical hypothyroid in Grade 1, 13 (26.0%) in Grade 2 and 4 (17.4%) in Grade 3. 4 hypothyroid subjects were (17.4%) in Grade 3. Figure 1 shows no significant negative correlation between FT3 and grades of fatty liver. Correlation between FT4 and grades of fatty liver is showing significant negative correlation between FT4 and grades of fatty liver (Figure 2 ). Significant positive correlation was found between TSH and grades of fatty liver (Figure 3 ). 
DISCUSSION
In this present study it was observed that 82 (52.9%) patients had grade 1 (mild), followed by 32.3% had grade 2 (moderate) and 14.8% had grade 3 (marked) fatty liver (Table-1 2013) found 44.2% of the respondents had NAFLD and among them half (52.9%) had a moderate grade fatty liver in contrast with the current study (7).
There was no statistically significant (p>0.05) difference with the grading of fatty liver with age. Although the mean age (41.1±7.1) was higher in Grade 3 in this study ( Table 2 ). The mean age of respondents with NAFLD in Cheah et al. (2013) study was 50 years, which is higher than the current study (7) . This may be explained by a bimodal age distribution of NAFLD by sex. In women, the prevalence of NAFLD peaks after age 50 years. Estrogens may be partially protective against steatosis (8) . The higher mean age may be due to geographical variations, racial, ethnic differences, genetic causes, different lifestyle and increased life expectancy may have significant impacts to developed fatty liver (9) .
In this study male to female ratio was almost 2:3 in the whole study subject (Table 3) , which indicates that fatty liver is more common in female subject, which is similar with Chung et al. (2012) study, where they found 62.4% were female (10).
In the present study it was observed that the mean BMI was significantly (p<0.05) higher in grade 3 (30.0±4.1) In the present study it was found that the mean FT3 and FT4 were significantly (p<0.05) reduced with increased grade of fatty liver and the mean TSH level was significantly (p<0.05) increased with increased grade of fatty liver (Table 5 ). In spearman's rank correlation test it was observed that no significant negative correlation (r= -0.101; p=0.175) between FT3 and fatty liver of the study population (Figure 1 ), but a significant negative correlation (r= -0.277; p=0.001) was observed between FT4 and fatty liver of the study population (Figure 2 ). On the other hand a significant positive correlation (r=0.325; p=0.001) was observed between TSH and fatty liver of the study patients ( Figure 3) . Pacifico et al. (2013) reported that elevated TSH concentrations were significantly associated with an increased prevalence of hepatic steatosis but no significant association in serum FT3 and FT4 levels. They also found a significant association between elevated TSH levels and metabolic variables (including hypertriglyceridemia and IR which are usually altered in fatty liver) (12) . Carulli et al. (2013) also reported that serum TSH levels, in the NASH group were significantly (p= 0.017) greater compared to the steatosis group (13) . This finding indicates that serum TSH concentration is increased with the severity of fatty liver disease.
Another population based study evaluated a relatively large numbers of healthy individuals in West Pomerania, a region of Northeast Germany showed that no consistent association of serum TSH and FT3 concentrations with hepatic steatosis. In contrast, serum FT4 concentrations were inversely associated with hepatic steatosis in men (odds ratio =0.04) and women (odds ratio =0.06) (14) . Chung et al. (2012) also reported that FT4 were inversely associated with an increased prevalence of NAFLD after adjustment for risk factors. In this study it was observed that serum FT 4 levels were significantly decreased with the grading of fatty liver (10) . 
CONCLUSION
Fatty liver disease is one of the most common chronic liver disease. Prevalence and burden of this disease is increasing with time. On the other hand, incidence of thyroid disorders are also common. In this study it was found that FT4 was negatively and TSH was positively correlated with increasing grades of fatty liver and there is an increasing trend of hypothyroidism with the increasing grades of fatty liver. So a routine thyroid hormone test of all the newly diagnosed fatty liver patients may be helpful to evaluate the patients as well as planning for the management. On the other hand fatty liver may also be evaluated in all hypothyroid patients.
